Senior Manager, Marketing, Lung Cancer
Revolution Medicines
Summary
Reporting directly to the Director, Marketing, Lung Cancer, this marketing leader will help develop and deliver Revolution Medicines’ marketing plans for the company’s lead RAS(ON) programs in preparation for anticipated launches. You will work within the Commercial team to develop marketing strategies and execute on critical marketing activities. This role will collaborate with cross-functional teams to provide a commercial marketing perspective on clinical, medical affairs, and market access initiatives. Additionally, this role will manage and partner with key external agencies.
Job description
Key responsibilities include:
- Operate as an ambassador of the company, establishing the organization as a trusted member of the healthcare community to all relevant stakeholders.
- Contribute to and help lead the development of effective strategic and promotional plans, shape launch strategy to align with full brand and portfolio strategy.
- Leverage deep understanding of oncology healthcare customers, including providers, key opinion leaders, patients, and market access stakeholders, to inform the brand strategic approach that drives customer behavior change and market performance.
- Lead implementation of brand/launch strategies through development of effective promotional materials for key customer segments (e.g., HCPs, Patients, KOLs, allied health professionals, market access stakeholders) and across multiple channels.
- Contribute to cross functional workstreams to support launch readiness and success.
- Leverage insights to inform stakeholder segmentation, channel mix, and targeting of customer segments.
- Ensure tactical execution is aligned to brand/launch strategies and stakeholder insights.
- Maintain deep knowledge of disease state, competitive, and market dynamics, informing potential pivots in strategic and executional approach as needed.
- Partner with internal stakeholders to develop and deliver impactful customer-facing content.
- Partner with Analytics & Insights to shape market research, inform key performance metrics, and measure the effectiveness of marketing initiatives.
- Ensure management of agency of record relationships, workflow, and budgets.
- Ensure strategic and tactical plans meet compliance and regulatory guidelines and company policies.
- Deliver marketing operating expenses within budget.
- Travel as needed to home office as applicable and external meetings and conferences.
- Other duties as assigned.
Requirements
- Bachelor’s degree required
- At least 5 years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and omnichannel marketing
- Strong leadership skills, with the ability to work well cross-functionally and influence across an organization at all levels
- Proven track record of developing and executing effective marketing initiatives
- Demonstrated analytical and problem-solving skills, leading to the development of innovative marketing initiatives
- Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
- Strong interpersonal skills, with demonstrated ability to lead and influence cross-functional partners
- Exceptional communication skills, including excellent written and verbal communication skills; possesses a professional, proactive demeanor
- Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patient
- Ability to represent Revolution Medicines well externally
- Preferred: MBA
- Preferred: Launch and customer-facing experience
- Preferred: Experience with targeted oncology products
- Preferred: Experience in a smaller, rapidly growing, company
Benefits
- Equity Awards
- Health Benefits
- Learning And Development Opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.